Back to Trades
Schneiderman Daniel H
Chief Financial OfficerCIK: 0001565536
Schneiderman Daniel H, Chief Financial Officer, has filed 2 insider trading reports covering 1 company. Total disclosed trading volume is $246.8K. Purchases and sales are approximately balanced over this period. The largest single filing involves Pasithea Therapeutics Corp. (KTTA). All transactions sourced from SEC Form 4 filings.
Total Volume
$246.8K
Purchases
$0
Sales
$0
Companies
1
Trading History (2 filings)
Grant
$20.0K
1 grant
Other
$0